Skip to main content

Advertisement

SpringerLink
Log in

Outcome of Chronic Daily Headache or Chronic Migraine

  • Chronic Daily Headache (SJ Wang, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Chronic daily headache (CDH) is a common neurological condition that affects 1–4 % of the general population. Recent epidemiological studies have shown that CDH is mainly represented by chronic migraine (CM). Owing to the frequent headaches, associated symptoms, and comorbid conditions associated with CDH/CM, disability, quality of life (QoL), economic burden, and treatment outcome have become important personal and social issues. There have been several studies assessing the disability, QoL, and economic burden associated with CDH/CM. These studies, conducted in different settings, consistently reported significantly higher disability and economic burden and lower QoL among CDH/CM patients compared to patients with episodic headache (EH) or episodic migraine (EM). Treatment outcome of CDH/CM is often poor. In this review, we describe and summarize the results of relevant studies performed to date.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

AMPP:

American Migraine Prevalence and Prevention

BT-A:

Botulinum toxin A

CDH:

Chronic daily headache

CM:

Chronic migraine

CTTH:

Chronic tension-type headache

ED:

Emergency department

EH:

Episodic headache

EM:

Episodic migraine

EUROHIS-QoL 8:

European Health Interview Survey-QoL 8

HRQoL:

Headache-related quality of life

IBMS:

International Burden of Migraine Study

ICHD-2:

The second edition of International Classification of Headache Disorders

ICHD-3 beta:

The third beta edition of International Classification of Headache Disorders

MIDAS:

Migraine disability assessment

MO:

Medication overuse

MSQ:

Migraine-Specific Quality of Life Questionnaire

QoL: Quality of Life RCM:

Refractory chronic migraine

SF-36:

36-item Short-Form Health Survey

TM:

Transformed migraine

WHOQoL-BREF:

Shortened version of World Health Organization Quality of Life Instrument-Abbreviation Version

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Dodick DW. Chronic daily headache. N Engl J Med. 2006;354(2):158–65.

    Article  PubMed  CAS  Google Scholar 

  2. Schwedt TJ. Chronic migraine. Br Med J. 2014;348:g1416.

    Article  Google Scholar 

  3. Stark RJ, Ravishankar K, Siow HC, Lee KS, Pepperle R, Wang S-J. Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic review. Cephalalgia. 2013;33(4):266–83.

    Article  PubMed  Google Scholar 

  4. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000;13(3):277–83.

    Article  PubMed  CAS  Google Scholar 

  5. Bigal M, Lipton R, Tepper S, Rapoport A, Sheftell F. Primary chronic daily headache and its subtypes in adolescents and adults. Neurology. 2004;63(5):843–7.

    Article  PubMed  CAS  Google Scholar 

  6. Lu S, Fuh J, Chen W, Juang K, Wang S. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001;21(10):980–6.

    Article  PubMed  CAS  Google Scholar 

  7. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.

    Article  Google Scholar 

  8. Headache Classificaation Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9–160.

    Google Scholar 

  9. Silberstein SD, Lipton RB, Dodick DW. Operational diagnostic criteria for chronic migraine: expert opinion. Headache. 2014;54(7):1258–66.

    Article  PubMed  Google Scholar 

  10. Manack AN, Buse DC, Lipton RB. Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep. 2011;15(1):70–8.

    Article  PubMed  Google Scholar 

  11. Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2009;30(5):599–609.

    Google Scholar 

  12. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–15. This international web-based cross-sectional study with participants from ten countries shed on the light of the severe disability of chronic migraine.

    Article  PubMed  CAS  Google Scholar 

  13. Chong CD, Dodick DW, Schlaggar BL, Schwedt TJ. Atypical age-related cortical thinning in episodic migraine. Cephalalgia. 2014;34(14):1115–24.

    Article  PubMed  Google Scholar 

  14. Leonardi M, Raggi A. Burden of migraine: international perspectives. Neurol Sci. 2013;34 Suppl 1:S117–8.

    Article  PubMed  Google Scholar 

  15. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–92.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013;14:1.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lanteri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31(7):837–50. This article showed extensive reviews of quality of life, disability, and economic burden of chronic daily headache or chronic migraine with elegant figure and tables.

    Article  PubMed  Google Scholar 

  18. Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43(4):336–42.

    Article  PubMed  Google Scholar 

  19. Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007;8 Suppl 1:S3–47.

    PubMed  Google Scholar 

  20. Fiane I, Haugland ME, Stovner LJ, Zwart JA, Bovim G, Hagen K. Sick leave is related to frequencies of migraine and non-migrainous headache—the HUNT Study. Cephalalgia. 2006;26(8):960–7.

    Article  PubMed  CAS  Google Scholar 

  21. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71(8):559–66.

    Article  PubMed  Google Scholar 

  22. Lanteri-Minet M, Auray JP, El Hasnaoui A, Dartigues JF, Duru G, Henry P, et al. Prevalence and description of chronic daily headache in the general population in France. Pain. 2003;102(1–2):143–9.

    Article  PubMed  Google Scholar 

  23. D’Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache. 2005;45(5):553–60.

    Article  PubMed  Google Scholar 

  24. Lanteri-Minet M. Economic burden and costs of chronic migraine. Curr Pain Headache Rep. 2014;18(1):1–6. An updated review on economic burden and costs of chronic migraine.

    Article  Google Scholar 

  25. Carod-Artal FJ. Tackling chronic migraine: current perspectives. J Pain Res. 2014;7:185–94.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D’Amico D. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci. 2004;25 Suppl 3:S105–7.

    Article  PubMed  Google Scholar 

  27. Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache. 2012;52(4):582–91.

    Article  PubMed  Google Scholar 

  28. Queiroz LP, Silva Junior AA. The prevalence and impact of headache in Brazil. Headache. 2015;55 Suppl 1:32–8.

    Article  PubMed  Google Scholar 

  29. Zebenholzer K, Andree C, Lechner A, Broessner G, Lampl C, Luthringshausen G, et al. Prevalence, management and burden of episodic and chronic headaches—a cross-sectional multicentre study in eight Austrian headache centres. J Headache Pain. 2015;16(1):531.

    Article  PubMed  Google Scholar 

  30. D’Amico D, Usai S, Grazzi L, Rigamonti A, Solari A, Leone M, et al. Quality of life and disability in primary chronic daily headaches. Neurol Sci. 2003;24 Suppl 2:S97–100.

    PubMed  Google Scholar 

  31. Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.

    Article  PubMed  Google Scholar 

  32. Abu Bakar N, Tanprawate S, Lambru G, Torkamani M, Jahanshahi M, Matharu M. Quality of life in primary headache disorders: a review. Cephalalgia. 2015:0333102415580099. Recent update of quality of life of migraine, tension-type headache, and chronic daily headache focusing with detailed description of assessing instrument and study quality .

  33. Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, et al. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015;35(7):563–78.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, et al. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache. 2012;52(3):409–21.

    Article  PubMed  Google Scholar 

  35. da Rocha NS, Power MJ, Bushnell DM, Fleck MP. The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF. Value Health. 2012;15(3):449–57.

    Article  PubMed  Google Scholar 

  36. Ware Jr JE, Sherbourne CD, The MOS. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.

    Article  PubMed  Google Scholar 

  37. Duru G, Auray JP, Gaudin AF, Dartigues JF, Henry P, Lanteri-Minet M, et al. Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache. 2004;44(6):571–80.

    Article  PubMed  Google Scholar 

  38. Barton-Donovan K, Blanchard EB. Psychosocial aspects of chronic daily headache. J Headache Pain. 2005;6(1):30–9.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Guitera V, Munoz P, Castillo J, Pascual J. Quality of life in chronic daily headache: a study in a general population. Neurology. 2002;58(7):1062–5.

    Article  PubMed  Google Scholar 

  40. Meletiche DM, Lofland JH, Young WB. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41(6):573–8.

    Article  PubMed  CAS  Google Scholar 

  41. Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain. 2001;89(2–3):285–92.

    Article  PubMed  CAS  Google Scholar 

  42. Coeytaux RR, Spierings EL. Prognostic factors, disability, and functional status among patients in a headache specialty practice. Cephalalgia. 2006;26(1):7–13. doi:10.1111/j.1468-2982.2005.00976.x.

    Article  PubMed  CAS  Google Scholar 

  43. Manzoni GC, Torelli P. Epidemiological classification and social impact of chronic headache. Intern Emerg Med. 2010;5 Suppl 1:S1–5.

    Article  PubMed  Google Scholar 

  44. Cavallini A, Micieli G, Bussone G, Rossi F, Nappi G. Headache and quality of life. Headache. 1995;35(1):29–35.

    Article  PubMed  CAS  Google Scholar 

  45. Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ. The global campaign, world health organization and lifting the burden: collaboration in action. J Headache Pain. 2011;12(3):273–4.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Steiner TJ, Gururaj G, Andree C, Katsarava Z, Ayzenberg I, Yu SY, et al. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain. 2014;15:3.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32.

    Article  PubMed  CAS  Google Scholar 

  48. Lipton R, Scher A, Steiner T, Bigal M, Kolodner K, Liberman J, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology. 2003;60(3):441–8.

    Article  PubMed  CAS  Google Scholar 

  49. Sanderson JC, Devine EB, Lipton RB, Bloudek LM, Varon SF, Blumenfeld AM, et al. Headache-related health resource utilisation in chronic and episodic migraine across six countries. J Neurol Neurosurg Psychiatry. 2013;84(12):1309–17.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2009;49(4):498–508.

    Article  PubMed  Google Scholar 

  51. Wang SJ, Wang PJ, Fuh JL, Peng KP, Ng K. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan. Cephalalgia. 2013;33(3):171–81.

    Article  PubMed  CAS  Google Scholar 

  52. Park JW, Moon HS, Kim JM, Lee KS, Chu MK. Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol. 2014;10(3):236–43.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Stewart WF, Wood GC, Manack A, Varon SF, Buse DC, Lipton RB. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010;52(1):8–14.

    Article  PubMed  Google Scholar 

  54. Lionetto L, Negro A, Palmisani S, Gentile G, Fiore MRD, Mercieri M, et al. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs. 2012;17(3):393–406.

    Article  PubMed  CAS  Google Scholar 

  55. Mulleners WM, McCrory DC, Linde M. Antiepileptics in migraine prophylaxis: an updated Cochrane review. Cephalalgia. 2015;35(1):51–62. A concise and updated review of migraine and chronic migraine prophylaxis.

    Article  PubMed  Google Scholar 

  56. Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S. Memantine in the preventive treatment of refractory migraine. Headache. 2008;48(9):1337–42.

    Article  PubMed  Google Scholar 

  57. Calandre EP, Garcia-Leiva JM, Rico-Villademoros F, Vilchez JS, Rodriguez-Lopez CM. Pregabalin in the treatment of chronic migraine: an open-label study. Clin Neuropharmacol. 2010;33(1):35–9.

    Article  PubMed  CAS  Google Scholar 

  58. Edvardsson B. Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study. Springer Plus. 2013;2(1):479.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Magalhães E, Menezes C, Cardeal M, Melo A. Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine. Clin Neurol Neurosurg. 2010;112(6):463–6.

    Article  PubMed  Google Scholar 

  60. Pascual-Gómez J, Alañá-García M, Oterino A, Leira R, Láinez-Andrés J. Preventive treatment of chronic migraine with zonisamide: a study in patients who are refractory or intolerant to topiramate. Rev Neurol. 2007;47(9):449–51.

    Google Scholar 

  61. Saper JR, Lake AE, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double‐blind, placebo‐controlled, multicenter outcome study. Headache. 2002;42(6):470–82.

    Article  PubMed  Google Scholar 

  62. Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain. 2008;9(1):37–41.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Pistoia F, Sacco S, Carolei A. Behavioral therapy for chronic migraine. Curr Pain Headache Rep. 2013;17(1):1–8.

    Article  Google Scholar 

  64. Reed K, Black S, Banta C, Will K. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2009;30(3):260–71.

    Google Scholar 

  65. Yang C, Chang M, Liu P, Li T, Hsieh C, Hwang K, et al. Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial. Cephalalgia. 2011;31(15):1510–21.

    Article  PubMed  Google Scholar 

  66. Diener H, Bussone G, Van Oene J, Lahaye M, Schwalen S, Goadsby P. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27(7):814–23.

    Article  PubMed  Google Scholar 

  67. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double‐blind, placebo‐controlled trial. Headache. 2007;47(2):170–80.

    Article  PubMed  Google Scholar 

  68. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965–73.

    Article  PubMed  CAS  Google Scholar 

  69. Storey J, Calder C, Hart D, Potter D. Topiramate in migraine prevention: a double‐blind, placebo‐controlled study. Headache. 2001;41(10):968–75.

    Article  PubMed  CAS  Google Scholar 

  70. Aurora S, Dodick D, Turkel C, DeGryse R, Silberstein S, Lipton R, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010;30(7):793–803.

    Article  PubMed  CAS  Google Scholar 

  71. Diener H, Dodick D, Aurora S, Turkel C, DeGryse R, Lipton R, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804–14.

    Article  PubMed  CAS  Google Scholar 

  72. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double‐blind, randomized, placebo‐controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921–36.

    Article  PubMed  Google Scholar 

  73. Naumann M, So Y, Argoff C, Childers M, Dykstra D, Gronseth G, et al. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70(19):1707–14.

    Article  PubMed  CAS  Google Scholar 

  74. Spira PJ, Beran RG. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology. 2003;61(12):1753–9.

    Article  PubMed  CAS  Google Scholar 

  75. Schulman EA, Lee Peterlin B, Lake AE, Lipton RB, Hanlon A, Siegel S, et al. Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache. 2009;49(4):509–18.

    Article  PubMed  Google Scholar 

  76. Irimia P, Palma J-A, Fernandez-Torron R, Martinez-Vila E. Refractory migraine in a headache clinic population. BMC Neurol. 2011;11(1):94.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Dodick DW, Silberstein SD, Reed KL, Deer TR, Slavin KV, Huh B, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2014;35(4):344–58.

    Article  PubMed  Google Scholar 

  78. DaSilva AF, Mendonca ME, Zaghi S, Lopes M, DosSantos MF, Spierings EL, et al. tDCS‐Induced analgesia and electrical fields in pain‐related neural networks in chronic migraine. Headache. 2012;52(8):1283–95.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, 40 Seokwoo-dong, Hwaseong-si, Gyeonggi-do, 445-170, South Korea

    Soo-Jin Cho

  2. Department of Neurology, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul, 158-710, South Korea

    Tae-Jin Song

  3. Department of Neurology, Sacred Heart Hospital, Hallym University College of Medicine, 896 Pyungchon-dong, Dongan-gu, Anyang-si, Gyeonggi-do, 14068, South Korea

    Min Kyung Chu

Authors
  1. Soo-Jin Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tae-Jin Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Kyung Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Min Kyung Chu.

Ethics declarations

Conflict of Interest

Soo-Jin Cho, Tae-Jin Song, and Min Kyung Chu declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Chronic Daily Headache

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cho, SJ., Song, TJ. & Chu, M.K. Outcome of Chronic Daily Headache or Chronic Migraine. Curr Pain Headache Rep 20, 2 (2016). https://doi.org/10.1007/s11916-015-0534-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-015-0534-8

Keywords

Search

Navigation